Nice | Rivaroxaban for treating PE and preventing recurrent embolism

2nd August 2013 by Louise Hudman

Another guideline about Rivaroxaban. Guidance was published in 2012 advising that Rivaroxaban could be used in the treatment of DVT. At that point, there was no guidance about its use in PEs. Since then a study has shown that it is as effective as Warfarin in the treatment of PE. Therefore this new guideline advises that Rivaroxaban can be used in the treatment of PE and for the prevention of recurrent PE and DVT.

Its main advantage is that it does not need monitoring. Its main disadvantage is that its effects are not easily reversible. It is also expensive.

 

Read more

No credit card details needed – it takes two minutes.

Join free trial

Login

Already a member? Login to view this content.

Login

"Joining NASGP's Locum Chambers in Essex after CCT has been a fantastic decision for me. The Chambers structure provides support with my locum work as well as a peer support network with regular meetings.

The Chambers support also extends to support with complaints when these occur. This is an amazing benefit that helps to minimise the professional isolation that can come with being a locum.

The Instant Book feature within LocumDeck makes arranging sessions easy. Whilst getting things set up initially does take a bit of work, this eventually pays off and the return on this initial time investment is impressive. New features are always being added based on feedback from members. "

Dr Shanil Shivji, Essex

See the full list of features within our NASGP membership plans

Membership